Next-Generation Cardiac Arrhythmia Treatment Systems

A suite of revolutionary cardiac arrhythmia treatment devices and methods that leverage AI, machine learning, and miniaturized technologies to provide personalized, real-time, and adaptive therapy optimization.

The original patent addressed the need for effective cardiac arrhythmia treatment devices, but its limitations included the need for invasive lead implantation and limited real-time adaptability. The new inventive concept addresses these limitations by introducing leadless pacemakers, neural network-based algorithms, and real-time optimization capabilities.

The inventive concept comprises a subcutaneously implantable pulse generator, a leadless cardiac pacemaker disposed within a chamber of the heart, and a neural network-based algorithm for real-time cardiac rhythm analysis and personalized therapy optimization. The system can also include a machine learning-based approach for optimizing pacing parameters, a miniaturized pulse generator implantable in a patient's ear, and a swarm of micro-robots deployable in a patient's heart. These components enable real-time cardiac rhythm analysis, personalized therapy optimization, and targeted electrical stimulation therapy.

The new inventive concept introduces the use of leadless pacemakers, neural network-based algorithms, and real-time optimization capabilities, which are not present in the original patent. These advancements enable more effective, personalized, and adaptive cardiac arrhythmia treatment.

Alternative embodiments of the inventive concept could include the use of different types of implantable devices, such as implantable cardioverter-defibrillators or cardiac resynchronization therapy devices. Variations could also include the integration of additional sensors or data sources, such as genomic data or wearable device data, to further enhance personalized therapy optimization.

The inventive concept has significant commercial potential in the cardiac arrhythmia treatment market, which is projected to grow significantly in the coming years. The target industries include medical device manufacturers, healthcare providers, and pharmaceutical companies.